{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:44:46Z","timestamp":1789998286310,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.anai.2024.05.014","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T16:59:08Z","timestamp":1717606748000},"page":"286-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-4100","authenticated-orcid":false,"given":"Jay A.","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnuva","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Dribin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.K.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Heimall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica G.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Dean","family":"Minniear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Shahzad","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Cosby A.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Stukus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Greenhawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2024.05.014_bib0001","unstructured":"Dupixent Package Insert. Vol. 2023. Accessed June 11, 2024. Available at: www.regeneron.com\/downloads\/dupixent_fpi.pdf."},{"key":"10.1016\/j.anai.2024.05.014_bib0002","unstructured":"Dupixent Canadian Product Monograph. Vol. 2023. Accessed June 11, 2024. Available at: https:\/\/pdf.hres.ca\/dpd_pm\/00070465.PDF."},{"issue":"26","key":"10.1016\/j.anai.2024.05.014_bib0003","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.anai.2024.05.014_bib0004","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anai.2024.05.014_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-021-00607-6","article-title":"Recommendations for vaccination in children with atopic dermatitis treated with dupilumab: a consensus meeting, 2020","volume":"22","author":"Martinez-Cabriales","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2024.05.014_bib0006","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions","volume":"64","author":"Brozek","year":"2009","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2024.05.014_bib0007","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations","volume":"66","author":"Brozek","year":"2011","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2024.05.014_bib0008","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1398-9995.2009.02083.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies","volume":"64","author":"Brozek","year":"2009","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2024.05.014_bib0009","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaci.2020.08.015","article-title":"Persistent, refractory, and biphasic anaphylaxis: a multidisciplinary Delphi study","volume":"146","author":"Dribin","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.014_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2021.01.003","article-title":"Severity grading system for acute allergic reactions: a multidisciplinary Delphi study","volume":"148","author":"Dribin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.05.014_bib0011","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"10.1016\/j.anai.2024.05.014_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacig.2021.12.003","article-title":"Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines","volume":"1","author":"Wechsler","year":"2022","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"2","key":"10.1016\/j.anai.2024.05.014_bib0013","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/pde.15518","article-title":"A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis","volume":"41","author":"Siegfried","year":"2024","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.014_bib0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaad.2018.07.048","article-title":"Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis","volume":"80","author":"Blauvelt","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.anai.2024.05.014_bib0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1164\/rccm.202111-2496LE","article-title":"Reduced COVID-19 vaccine response in patients treated with biologic therapies for asthma","volume":"205","author":"Runnstrom","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.anai.2024.05.014_bib0016","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1164\/rccm.202203-0599LE","article-title":"SARS-CoV-2 mRNA vaccine antibody response in patients with asthma receiving biologic therapy: a real-world analysis","volume":"206","author":"Liao","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2024.05.014_bib0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bjd.21038","article-title":"Examining the risk of breakthrough infection and COVID-19 vaccination safety in patients with atopic dermatitis","volume":"187","author":"Pakhchanian","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2024.05.014_bib0018","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.anai.2022.03.019","article-title":"The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis","volume":"128","author":"Ungar","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.05.014_bib0019","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/all.15540","article-title":"The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients","volume":"78","author":"Ungar","year":"2023","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2024.05.014_bib0020","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S2665-9913(22)00034-0","article-title":"Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study","volume":"4","author":"Wieske","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.anai.2024.05.014_bib0021","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/0091-6749(88)90873-1","article-title":"Impaired antibody responses in the hyperimmunoglobulin E syndrome","volume":"81","author":"Leung","year":"1988","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.05.014_bib0022","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.118.4.1042","article-title":"Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers","volume":"118","author":"Sharma","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.anai.2024.05.014_bib0023","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1016\/j.anai.2024.10.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T02:39:43Z","timestamp":1729564783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624003375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1081120624003375"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.014","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.anai.2024.10.023","asserted-by":"object"}]},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}